NCT05559866View on ClinicalTrials.gov

Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

August 2, 2024

Study Completion Date

January 17, 2025

Conditions
Obesity
Interventions
DEVICE

Apollo ESG with ERBE HAPC

Utilizing two approved devices in combination to assess durability of suturing.

DEVICE

Apollo ESG

Using only Apollo ESG as approved per label.

Trial Locations (1)

55905

Mayo Clinic Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators (1)

Erbe Elektromedizin GmbH
All Listed Sponsors
collaborator

Erbe Elektromedizin GmbH

INDUSTRY

lead

Mayo Clinic

OTHER

NCT05559866 - Hybrid Argon Plasma Coagulation and Endoscopic Sleeve Gastroplasty Trial | Biotech Hunter | Biotech Hunter